What does CUSIP 269796108 represent in this 13F holders report?

CUSIP 269796108 is the security identifier for EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock in Q4 2025?

2 institutional investors reported EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock for Q4 2025. Use the holders table for investor-level position and value details.

EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX)

CUSIP: 269796108

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock
Shares outstanding: 13,080,549
Total 13F shares: 12,350
Share change: 0
Total reported value: $8,645
Price per share: $0.70
Number of holders: 2

Quarterly Holders Quick Answers

What is CUSIP 269796108?
CUSIP 269796108 identifies EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2025

Recent filing periods for CUSIP 269796108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q4 2025

As of 31 Dec 2025, EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,350 shares. The largest 2 holders included Stanley-Laman Group, Ltd. and Archer Investment Corp. This page lists 2 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.